Learn more

PE CORP NY

Overview
  • Total Patents
    719
About

PE CORP NY has a total of 719 patent applications. Its first patent ever was published in 1988. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are SERONO GENETICS INST SA, KAZUSA DNA RES INST FOUNDATION and GENSET SA.

Patent filings in countries

World map showing PE CORP NYs patent filings in countries

Patent filings per year

Chart showing PE CORP NYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Beasley Ellen M 463
#2 Di Francesco Valentina 311
#3 Ketchum Karen A 189
#4 Yan Chunhua 155
#5 Wei Ming-Hui 138
#6 Francesco Valentina Di 94
#7 Ye Jane 77
#8 Guegler Karl 71
#9 Gong Fangcheng 54
#10 Merkulov Gennady V 50

Latest patents

Publication Filing date Title
AU2003200550B2 Multi-well microfiltration apparatus
AU2002326950A1 Membrane transportable fluorescent substrates
US2003022217A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US2003022299A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US2003022208A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO02095049A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002257266A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
CA2445791A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
WO02088321A2 Concentration and purification of analytes using electric fields
CA2444504A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
AU2002314733A1 Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof
CA2443685A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO02079432A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO02079233A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
EP1383803A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO02079450A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
CA2442843A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
CA2442607A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr protein, and uses thereof
WO02077192A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
CA2442579A1 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof